Coloplast Finance BV, founded in Denmark in 2010, serves as the financing arm of Coloplast A/S, focusing on managing the company’s financial operations and optimizing capital structure. The firm primarily offers financing solutions, including bonds, to support the growth and development of Coloplast’s medical devices and healthcare products aimed at improving the lives of individuals dealing with intimate health challenges.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| COLOBD 2.25% 2027-05-19 EURColoplast Finance BV | Netherlands | 2027-05-19 | 2.250 | 2.47 |
| COLOBD 2.75% 2030-05-19 EURColoplast Finance BV | Netherlands | 2030-05-19 | 2.750 | 2.95 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Coloplast Finance BV has been actively issuing bonds to fund its initiatives. Notably, the company first entered the bond market in 2011 with a significant €500 million issuance to support expansion efforts. As of 2023, Coloplast Finance BV’s bonds have achieved yields that are competitive within the healthcare sector, with recent issuances also showcasing green financing features aimed at promoting sustainability in healthcare. The company maintains a strong reputation for its solid credit ratings, reflecting its stable financial standing and effective management of corporate debts.